Warning
MACLEODS PHARMA USA Recalls Levothyroxine Sodium Tablets USP 150 mcg
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0403-2026Drug / Pharmaceutical
MACLEODS PHARMA USA Recalls Levothyroxine Sodium Tablets USP 150 mcg
MACLEODS PHARMA USA, INC · Class II — Moderate Risk
Product Description
Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Princeton, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Sarigam, Valsad, Guajarat, INDIA NDC 33342-401-44
Reason for Recall
Subpotent Drug
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
Nationwide
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
A Class II FDA recall has been issued for a pharmaceutical product from MACLEODS PHARMA USA, INC, initiated on February 26, 2026. Subpotent Drug. This recall covers 1315 bottles, distributed nationwide. While not the highest severity, consumers should exercise caution and stop using the product until the recall is resolved.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medication Defects.